The Center is dedicated to offering its patients access to the latest clinical trials. In fact, a certified oncology research nurse oversees all the trials and meets regularly with the patients who are participating. Currently the Center is participating in the following research studies:

 Breast Cancer

• Adjuvant – Her2Neu positive, Node positive or High Risk Node
• 1^st Metastatic Her2Neu positive
• Up to 3^rd line Metastatic
• Locally or advanced or loco regional recurrence or up to 2^nd line metastatic
• ER or PR positive; Her2Neu Negative
• 2^nd or 3^rd line locally advanced or metastatic Her2Neu positive

 Chronic Lymphocytic Leukemia

• 1^st line elderly patients (65 years of age or older)
• Maintenance after completion of 2^nd line therapy

Colorectal Cancer

• 1^st line locally advanced or stage IV
• 2^nd line mets after failure of 5FU/Xeloda, Oxaliplatin and Avastin

 Lymphoma, Diffuse Large B-Cell Non-Hodgkin’s Lymphoma

• 1^st line

 Multiple Myeloma

• 1^st line

 Non-Small Cell Lung Cancer Stage IIIB/IV (non-smoker or limited smoking history)

• 1^st line
• Squamous Cell Only – 1^st line IIIB with malignant effusion, IV, or recurrent disease after complete surgical resection of Stage I or II.
• 1^st line IIIB w/Pleural Effusion or IV (nonsquamous)
• Women Only with recurrence after XRT or surgery, stage IIIB or IV Disease
• SD, PR or CR following 2-6 cycles of 1^st line chemo for stage III or IV
• 2^nd Line IIIB/IV or recurrent (non-squamous)